At a glance
ClinicalIndex Comparison RecordN/ACompleted· 115 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
FlowTriever for Acute Massive Pulmonary Embolism (FLAME)
In Brief
An observational study for PE - Pulmonary Embolism and PE - Pulmonary Thromboembolism. Completed, enrolled 115 participants across 11 sites.
Detailed Summary
To evaluate treatment outcomes of patients diagnosed with high-risk (massive) pulmonary embolism
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedMar 2021
Enrollment StartMar 2021
Primary CompletionDec 2022
TodayJul 2026
First PostedMar 12, 2021
Enrollment StartMar 16, 2021
Primary CompletionDec 19, 2022
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 5.3 years ago